{"id":493,"date":"2007-08-01T12:00:00","date_gmt":"2007-08-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2007\/probleme-mit-multiresistenten-krankheitserregern-was-ist-zu-tun"},"modified":"2007-08-01T12:00:00","modified_gmt":"2007-08-01T10:00:00","slug":"probleme-mit-multiresistenten-krankheitserregern-was-ist-zu-tun","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2007\/probleme-mit-multiresistenten-krankheitserregern-was-ist-zu-tun","title":{"rendered":"Probleme mit multiresistenten Krankheitserregern: Was ist zu tun?"},"content":{"rendered":"<p>p >Zusammenfassung: Infektionen mit multiresistenten Erregern f\u00fchren weltweit zu erh\u00f6hter Letalit\u00e4t und steigenden Kosten. Nur durch konsequent durchgef\u00fchrte Kontrollma\u00dfnahmen in allen medizinischen Bereichen (ambulant, station\u00e4r, Pflegeeinrichtungen) l\u00e4sst sich die Verbreitung dieser Erreger eind\u00e4mmen. Dazu geh\u00f6ren Dekolonisation, mikrobiologisches Screening und Diagnostik, standardisierte Hygiene-Ma\u00dfnahmen, Isolierung der Betroffenen und sehr restriktiver Einsatz von Antibiotika. In Anbetracht der H\u00e4ufung [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>p >Zusammenfassung: Infektionen mit multiresistenten Erregern f\u00fchren weltweit zu erh\u00f6hter Letalit\u00e4t und steigenden Kosten. Nur durch konsequent durchgef\u00fchrte Kontrollma\u00dfnahmen in allen medizinischen Bereichen (ambulant, station\u00e4r, Pflegeeinrichtungen) l\u00e4sst sich die Verbreitung dieser Erreger eind\u00e4mmen. Dazu geh\u00f6ren Dekolonisation, mikrobiologisches Screening und Diagnostik, standardisierte Hygiene-Ma\u00dfnahmen, Isolierung der Betroffenen und sehr restriktiver Einsatz von Antibiotika. In Anbetracht der H\u00e4ufung [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[960,965,962,961,964,963,966,958,959,970,968,333,967,969,971,973,972,955,956,941,952,954,341,957,953],"class_list":["post-493","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-carbapenem","tag-desinfektion","tag-enterococcus-faecalis","tag-enterococcus-faecium","tag-enterokokken","tag-ertapenem","tag-esbl","tag-extended-spectrum-betalactamasen","tag-extended-spectrum-betalactamases","tag-imipenem","tag-linezolid","tag-meropenem","tag-mrsa","tag-mssa","tag-multiresistente-bakterien","tag-multiresistente-staphylokokken","tag-mupirocin","tag-quinupristin-dalfopristin","tag-staphylococcus-aureus","tag-staphylokokken","tag-teicoplanin","tag-tigecyclin","tag-vancomycin","tag-vancomycin-resistente-enterokokken","tag-vre"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=493"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/493\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}